ABBV-085 is an antibody drug conjugate (ADC) being investigated to treat advanced solid tumors.

Type of Molecule

Biologic

Target

LRRC15

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Solid Tumors New Indication Phase 1